Diagnostic tools in male infertility-the question of sperm dysfunction

Asian Journal of Andrology

Volumn 13, Issue 1, 2011, Pages 53-58

  Barratt, Christopher L R ^a,b   Mansell, Steven ^a   Beaton, Catherine ^a   Tardif, Steve ^a   Oxenham, Senga K ^a  

^a UNIVERSITY OF DUNDEE   (United Kingdom)

^b NINEWELLS HOSPITAL   (United Kingdom)

Author keywords

gamete biomarker; male fertility; sperm biomarker; sperm dysfunction

Indexed keywords

BIOLOGICAL MARKER; MEMBRANE PROTEIN; MESSENGER RNA; PROTEIN ZONADHESIN; UNCLASSIFIED DRUG;

CALCIUM MOBILIZATION; DIAGNOSTIC PROCEDURE; HUMAN; INTRACYTOPLASMIC SPERM INJECTION; MALE INFERTILITY; NONHUMAN; REVIEW; SEMEN ANALYSIS; SPERMATOZOON ABNORMALITY; SPERMATOZOON CAPACITATION; STAFF TRAINING;

ANIMALS; HUMANS; INFERTILITY, MALE; MALE; SPERM COUNT; SPERMATOZOA;

EID: 78650991287     PISSN: 1008682X     EISSN: 17457262     Source Type: Journal    
DOI: 10.1038/aja.2010.63     Document Type: Review

References (63)

1. Boivin J, Bunting L, Collins JA, Nygren KG. International estimates of infertility prevalence and treatment-seeking: potential need and demand for infertility medical care. Hum Reprod 2007; 22: 1506-12.
2. Hull MG, Glazener CM, Kelly NJ, Conway DI, Foster PA et al. Population study of causes, treatment, and outcome of infertility. Br Med J (Clin Res Ed) 1985; 291: 1693-7.
3. Irvine DS. Epidemiology and aetiology of male infertility. Hum Reprod 1998; 13 Suppl 1: 33-44.
4. Aitken RJ. Sperm function tests and fertility. Int J Androl 2006; 29: 69-75.
5. World Health Organization. WHO Laboratory Manual for the Examination and Processing of Human Semen. 5th edn. Geneva: WHO Health Organization, 2010. http://www.who.int/reproductivehealth/publications/infertility/9789241547789/en/ .
6. Barratt CL. On the accuracy and clinical value of semen laboratory tests. Hum Reprod 1995; 10: 250-2.
7. de Jonge CJ, Barratt CL. WHO manual...who should care? Hum Reprod 1999; 14: 2431-3.
8. Mortimer D. Practical Laboratory Andrology. Oxford: Oxford University Press; 1994.
9. Riddell D, Pacey A, Whittington K. Lack of compliance by UK andrology laboratories with World Health Organization recommendations for sperm morphology assessment. Hum Reprod 2005; 20: 3441-5.
10. Ombelet W, Pollet H, Bosmans E, Vereecken A. Results of a questionnaire on sperm morphology assessment. Hum Reprod 1997; 12: 1015-20.
11. Pacey AA. Quality assurance and quality control in the laboratory andrology. Asian J Androl 2010; 12: 21-5.
12. Björndahl L, Barratt CL, Fraser LR, Kvist U, Mortimer D. ESHRE basic semen analysis courses 1995-1999: immediate beneficial effects of standardized training. Hum Reprod 2002; 17: 1299-305.
13. Franken DR, Aneck-Hahn N, Lombaard C, Kruger TF. Semenology training programs: years experience. Fertil Steril e-pub ahead of print 28 May 2010; PMID: 20553675.
14. Pacey AA. Is quality assurance in semen analysis still really necessary? A view from the andrology laboratory. Hum Reprod 2006; 21: 1105-9.
15. Holt WV. Is quality assurance in semen analysis still really necessary? A spermatologists viewpoint. Hum Reprod 2005; 20: 2983-6.
16. Hargreave TB, Elton RA. Fecundability rates from an infertile male population. Br J Urol 1986; 58: 194-7.
17. Guzick DS, Overstreet JW, Factor-Litvak P, Brazil CK, Nakajima ST et al. Sperm morphology, motility, and concentration in fertile and infertile men. N Engl J Med 2001; 345: 1388-93.
18. Kilani Z, Ismail R, Ghunaim S, Mohamed H, Hughes D et al. Evaluation and treatment of familial globozoospermia in five brothers. Fertil Steril 2004; 82: 1436-9.
19. Tomlinson MJ, Kessopoulou E, Barratt CL. The diagnostic and prognostic value of traditional semen parameters. J Androl 1999; 20: 588-93.
20. Lefièvre L, Bedu-Addo K, Conner SJ, Machado-Oliveira GS, Chen Y et al, Counting sperm does not add up any more: time for a new equation? Reproduction, 2007, 133: 675-84.
21. MacLeod J, Gold RZ. The male factor in fertility and infertility. II. Spermatozoon counts in 1000 men of known fertility and in 1000 cases of infertile marriage. J Urol 1951; 66: 436-49.
22. Cooper TG, Noonan E, von Eckardstein S, Auger J, Baker HW et al. World Health Organization reference values for human semen characteristics. Hum Reprod Update 2010; 16: 231-45.
23. Ford WC. Comments on the release of the 5th edition of the WHO Laboratory Manual for the Examination and Processing of Human Semen. Asian J Androl 2010; 12: 59-63.
24. Baibakov B, Gauthier L, Talbot P, Rankin TL, Dean J. Sperm binding to the zona pellucida is not sufficient to induce acrosome exocytosis. Development 2007; 134: 933-43.
25. Liu DY, Liu ML, Baker HW. Enhancement of sperm-zona pellucida (ZP) binding capacity by activation of protein kinase A and C pathways in certain infertile men with defective sperm-ZP binding. Hum Reprod 2009; 24: 20-7.
26. Gupta SK, Bansal P, Ganguly A, Bhandari B, Chakrabarti K. Human zona pellucida glycoproteins: functional relevance during fertilization. J Reprod Immunol 2009; 83: 50-5.
27. Costello S, Michelangeli F, Nash K, Lefievre L, Morris J et al. Ca21-stores in sperm: their identities and functions. Reproduction 2009; 138: 425-37.
28. Publicover S, Harper CV, Barratt C. Ca21i signalling in sperm-making the most of what youve got. Nat Cell Biol 2007; 9: 235-242.
29. Krausz C, Bonaccorsi L, Maggio P, Luconi M, Criscuoli L et al. Two functional assays of sperm responsiveness to progesterone and their predictive values in in-vitro fertilization. Hum Reprod 1996; 11:1661-7.
30. Luconi M, Francavilla F, Porazzi I, Macerola B, Forti G et al. Human spermatozoa as a model for studying membrane receptors mediating rapid nongenomic effects of progesterone and estrogens. Steroids 2004; 69: 553-9.
31. Lewis SE. Is sperm evaluation useful in predicting human fertility? Review. Reproduction 2007; 134: 31-40.
32. Dirican EK, Ozgü n OD, Akarsu S, Akin KO, Ercan O et al. Clinical outcome of magnetic activated cell sorting of non-apoptotic spermatozoa before density gradient centrifugation for assisted reproduction. J Assist Reprod Genet 2008; 25: 375-81.
33. Kheirollahi-Kouhestani M, Razavi S, Tavalaee M, Deemeh MR, Mardani M et al. Selection of sperm based on combined density gradient and Zeta method may improve ICSI outcome. Hum Reprod 2009; 24: 2409-16.
34. Nasr-Esfahani MH, Razavi S, Vahdati AA, Fathi F, Tavalaee M. Evaluation of sperm selection procedure based on hyaluronic acid binding ability on ICSI outcome. J Assist Reprod Genet 2008; 25: 197-203.
35. Parmegiani L, Cognigni GE, Ciampaglia W, Pocognoli P, Marchi F et al. Efficiency of hyaluronic acid (HA) sperm selection. J Assist Reprod Genet 2010; 27: 13-6.
36. Parmegiani L, Cognigni GE, Bernardi S, Troilo E, Ciampaglia W et al. Physiologic ICSI: hyaluronic acid (HA) favours selection of spermatozoa without DNA fragmentation and with normal nucleus, resulting in improvement of embryo quality. Fertil Steril 2010; 93: 598-604.
37. Bartoov B, Berkovitz A, Eltes F, Kogosovsky A, Yagoda A et al. Pregnancy rates are higher with intracytoplasmic morphologically selection sperm injection than with conventional intracytoplasmic injection. Fertil Steril 2003; 80(6): 1413-9.
38. Berkovitz A, Eltes F, Yaari S, Katz N, Barr I et al. The morphological normalcy of the sperm nucleus and pregnancy rate of intracytoplasmic injection with morphologically selected sperm. Hum Reprod 2005; 20: 185-90.
39. Hazout A, Dumont-Hassan M, Junca AM, Cohen Bacrie P, Tesarik J. Highmagnification ICSI overcomes paternal effect resistant to conventional ICSI. Reprod Biomed Online 2006; 12: 19-25.
40. Antinori M, Licata E, Dani G, Cerusico F, Versaci C et al. Intracytoplasmic morphologically selected sperm injection: prospective randomized trial. Reprod Biomed Online 2008; 16: 835-41.
41. Cohen J. Cross-overs, sperm redundancy and their close association. Heredity 1973; 31: 408-13.
42. Aitken RJ, Koppers AJ. Apoptosis and DNA damage in human spermatozoa. Asian J Androl; e-pub ahead of print 30 August 2010; PMID: 20802502.
43. Conner SJ, Lefièvre L, Kirkman-Brown JC, Michelangeli F, Jimenez-Gonzalez C et al. Understanding the physiology of pre-ferilisation events in the human spermatozoa-a necessary prerequisite to developing rational therapy. Soc Reprod Suppl 2007; 63: 237-256.
44. Hardy DM, Garbers DL. Species-specific binding of sperm proteins to the extracellular matrix (zona pellucida) of the egg. J Biol Chem 1994; 269: 19000-400.
45. Gao Z, Garbers DL. Species diversity in the structure of zonadhesin, a sperm-specific membrane protein containing multiple cell adhesion molecule-like domains. J Biol Chem 1998; 273: 4315-21.
46. Olson GE, Winfrey VP, Nagdas SK. Acrosome biogenesis in the hamster: ultrastructurally distinct matrix regions are assembled from common precursor polypeptide. Biol Reprod 1998; 58: 361-70.
47. Tardif S, Brady HA, Breazeale KR, Bi M, Thompson LD et al. Zonadhesin D3-polypeptides vary among species but are similar in Equus species capable of interbreeding. Biol Reprod 2010; 82: 413-21.
48. Tardif S, Wilson MD, Wagner R, Hunt P, Gertsenstein M et al. Zonadhesin is essential for species specificity of sperm adhesion to the egg zona pellucida. J Biol Chem 2010; 285: 24863-70.
49. Coppola MA, Klotz KL, Kim KA, Cho HY, Kang J, Shetty J, Howards SS, Flickinger CJ, Herr JC. SpermCheck Fertility, an immunodiagnostic home test that detects normozoospermia and severe oligozoospermia. Hum Reprod 2010; 25: 853-61.
50. Segerink LI, Sprenkels AJ, ter Braak PM, Vermes I, van den Berg A. On-chip determination of spermatozoa concentration using electrical impedance measurements. Lab Chip 2010; 10: 1018-24.
51. Bjorndahl L, Kirkman-Brown J, Hart G, Rattle S, Barratt CL. Development of a novel home sperm test. Hum Reprod 2006; 21: 145-9.
52. Miller D, Tang PZ, Skinner C, Lilford R. Differential RNA fingerprinting as a tool in the analysis of spermatozoal gene expression. Hum Reprod 1994; 9: 864-9.
53. Lalancette C, Miller D, Li Y, Krawetz SA. Paternal contributions: new functional insights for spermatozoal RNA. J Cell Biochem 2008; 104: 1570-9.
54. Baker MA, Reeves G, Hetherington L, Muller J, Baur I et al. Identification of gene products present in the Triton X soluble and insoluble fractions of human spermatozoa lysates using LC-MS/MS analysis. Proteomics Clin Appl 2007; 1: 524-32.
55. Oxenham SK. Sperm proteomics: thinking outside the collision cell. J Androl 2010; 31: 431-3.
56. Oliva R, de Mateo S, Estanyol JM. Sperm cell proteomics. Proteomics 2009; 9: 1004-17.
57. Findlay GD, Swanson WJ. Proteomics enhances evolutionary and functional analysis of reproductive proteins. Bioessays 2010; 32: 26-36.
58. Zhao C, Huo R, Wang FQ, Lin M, Zhou ZM et al. Indentification of several proteins involved in regulation of sperm motility by proteomic analysis. Fertil Steril 2007; 87: 436-8.
59. Goodsaid FM, Mendrick DL. Translational medicine and the value of biomarker qualification. Sci Transl Med 2010; 2: 47ps44.
60. Huser T, Orme CA, Hollars CW, Corzett MH, Balhorn R. Raman spectroscopy of DNA packaging in individual human sperm cells distinguishes normal from abnormal cells. J Biophotonics 2009; 2: 322-32.
61. Barratt CL, Aitken RJ, Bjö rndahl L, Carrell DT, de Boer P et al. SpermDNA: organization, protection and vulnerability: from basic science to clinical applications-a position report. Hum Reprod 2010; 25: 824-38.
62. Gluud C, Gluud LL. Evidence based diagnostics. BMJ 2005; 330: 724-6.
63. Bossuyt PM, Irwig L, Craig J, Glasziou P. Comparative accuracy: assessing new tests against existing diagnostic pathways. BMJ 2006; 332: 1089-92.